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error in lung clearance index except at lung volumes below 
1,500 ml.  Conclusions: The open-circuit MBW system utilis-
ing SF 6 as the inert tracer gas and a photoacoustic gas analy-
ser is both accurate and repeatable within the adult range of 
lung volumes. Further modifications would be required be-
fore its use in young children or infants. 
 © 2014 S. Karger AG, Basel 
 Introduction 
 Multiple-breath inert gas washout (MBW) is a tech-
nique for assessing the non-uniformity of ventilation dis-
tribution in the lungs by measuring the efficiency with 
which an inert tracer gas is washed out of the lungs  [1] . 
The current gold-standard MBW system is the respira-
tory mass spectrometer  [1] , but this is expensive and lacks 
portability. An alternative system based upon a modified 
photoacoustic gas analyser (Innocor TM , Innovision A/S, 
Odense, Denmark) and 0.2% sulphur hexafluoride (SF 6 ) 
as the tracer gas has been developed, and shown to be 
both repeatable and practical  [2] , but its accuracy has not 
been formally validated. The functional residual capacity 
(FRC) may be derived from an MBW by dividing the total 
volume of inert gas expired by the difference between the 
inert gas concentrations at the beginning and end of the 
washout period  [3] . Current guidelines recommend that 
MBW systems are validated by determining FRC mea-
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 Abstract 
 Background: The respiratory mass spectrometer is the cur-
rent gold-standard technique for performing multiple-
breath inert gas washout (MBW), but is expensive and lacks 
portability. A number of alternative techniques have recent-
ly been described.  Objectives: We aimed to validate, using 
an in vitro lung model, an open-circuit MBW system that uti-
lises a portable photoacoustic gas analyser, with sulphur 
hexafluoride (SF 6 ) as the inert tracer gas.  Methods: An acryl-
ic glass lung model was utilised to assess the accuracy of 
functional residual capacity (FRC) measurements derived 
from MBW. Measurements were performed in triplicate at 20 
combinations of simulated FRC, tidal volume and respiratory 
rate. FRC measured using MBW (FRC mbw ) was compared to 
FRC calculated from the known dimensions of the model 
(FRC calc ). MBW was also performed in 10 healthy subjects and 
14 patients with asthma.  Results: The MBW system mea-
sured FRC with high precision. The mean bias of FRC mbw with 
respect to FRC calc was –0.4% (95% limits of agreement of –4.6 
and 3.9%). The mean coefficient of variation of triplicate FRC 
measurements was 4.0% in vivo and 1.0% in vitro. MBW 
slightly underestimated low lung volumes and overestimat-
ed high lung volumes, but this did not cause a significant 
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surement accuracy, and in particular that measured FRC 
values should lie within 5% of known volumes, at least 
95% of the time  [1] . Accurate FRC determination de-
pends critically upon correct flow and gas concentration 
measurements, precise synchronisation of these signals, 
and adequate conversion of measured flows and volumes 
to body temperature, pressure and water vapour satura-
tion (BTPS) conditions. These are the same technical fac-
tors that influence the accuracy of clinically relevant pa-
rameters such as the lung clearance index (LCI). FRC is a 
suitable end-point for quality control and methodologi-
cal validation because measured values may be readily 
compared to a gold standard, such as the known volume 
of an in vitro lung model. Current guidelines  [1] recom-
mend that MBW systems are validated using in vitro lung 
models incorporating realistic BTPS conditions, as previ-
ously described by Singer et al.  [4] . We aimed to utilise 
this lung model to validate the MBW method of Horsley 
et al.  [2] , as well as to compare the variability of triplicate 
MBW tests performed in vitro and in vivo. The primary 
outcome of the study was the percentage difference be-
tween measured and calculated FRC measurements using 
the in vitro lung model, with satisfactory accuracy being 
defined as a percentage difference of between –5 and 5% 
for at least 95% of the measurements. Secondary out-
comes were the dependence, if any, of the measurement 
bias on absolute FRC values or the respiratory rate, as well 
as the difference in measurement variability between in 
vitro and in vivo measurements.
 Materials and Methods 
 Description of the Modified Innocor Photoacoustic Gas 
Analyser 
 The Innocor photoacoustic gas analyser is a small, portable de-
vice which weighs approximately 8 kg and has dimensions of 35 × 
29 × 26 cm. It was originally designed to measure cardiac output 
at rest and during exercise, by measuring the difference in absorp-
tion between N 2 O, which crosses the alveolar-capillary membrane, 
and SF 6 , which does not. In addition, the device can simultane-
ously measure oxygen uptake and carbon dioxide production. At 
the heart of the Innocor device is a photoacoustic gas analyser, 
which is capable of measuring the concentrations of CO 2 , SF 6 and 
N 2 O at high accuracy and temporal resolution. A separate oxygen 
analyser is placed in series before the photoacoustic analyser. A 
photograph of the device is shown in  figure 1 a.
 The Innocor device has recently been modified for the perfor-
mance of MBW  [2] , and we modified our device in a similar manner. 
Firstly, the commercially supplied patient interface has an excessive 
dead space for inert gas washout, and was therefore replaced with a 
mesh-type pneumotachometer (3,700 series, Hans Rudolph Inc., 
Kansas City, Mo., USA), heated to 37   °   C using a 3850A series pneu-
motachometer heater (Hans Rudolph Inc.). The patient interface, 
shown in  figure 1 b, comprised a rubber mouthpiece connected to a 
bacterial filter (Clear-Guard Midi, Intersurgical, Wokingham, UK), 
which was in turn connected to the pneumotachometer. The gas sam-
ple needle was positioned distal to the pneumotachometer mesh, re-
sulting in a minimal post-capillary dead space of 2.65 ml. The pre-
capillary dead space was calculated as 40 ml for in vitro tests and 54.6 
ml for in vivo tests (due to the additional dead space of the rubber 
mouthpiece). A further modification made to our Innocor device was 
to manually bypass the oxygen analyser by diverting the internal Na-
fion tubing directly into the photoacoustic analyser. This had the effect 
of reducing both the gas analyser rise time and the flow-gas delay time.
 Fig. 1. Photoacoustic gas analyser ( a ) and patient interface ( b ). 
Co
lo
r v
er
si
on
 a
va
ila
bl
e 
on
lin
e
Mouthpiece Pneumotachometer
Gas sample line
Bacterial filter Pneumotachometer heater
a b
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.2
06
.7
5 
- 1
/2
9/
20
15
 4
:4
4:
43
 P
M
 Gonem/Singer/Corkill/Singapuri/
Siddiqui/Gustafsson 
 Respiration 2014;87:462–468 
DOI: 10.1159/000357786
464
 Description of the Lung Model 
 We used a simple one-compartment model of the lung consist-
ing of an enclosed clear acrylic glass tank (Soloplex, Tidaholm, 
Sweden), partly filled with water at 37 o C, as previously described 
 [4] . In order to achieve BTPS conditions within the phantom lung, 
it was enclosed within a further acrylic glass tank containing water 
that was kept at a constant temperature of 37   °   C by a thermostat. 
The dimensions of the outer and inner tanks are shown in  figure 
2 . The inner tank was fitted with an off-centre vertical partition 
that divided it into a larger and a smaller section. The partition did 
not reach the base of the tank, thus allowing the two sides to com-
municate, but the water level was always kept above the lower end 
of the partition. The lid of the larger section was connected to a 
bi-level positive airway pressure ventilator (Vivo 30, Breas Medical 
AB, Mölnlycke, Sweden) which exerted alternating high and low 
pressures on the water surface, designated inspiratory and expira-
tory positive airway pressures (IPAP and EPAP), respectively. Due 
to the communication below the partition, this caused the water 
level in the smaller section to alternately rise and fall, simulating 
diaphragmatic movement. The IPAP setting on the ventilator de-
termined the FRC of the phantom lung, whilst the difference be-
tween the IPAP and EPAP settings determined the tidal volume 
(VT). The lid above the smaller section was modified to fit the pa-
tient interface described above, with the exception that the rubber 
mouthpiece was omitted and the lung model attached directly to 
the bacterial filter.
 In vitro Testing Procedure 
 Before testing began, a volume calibration was performed using 
a 1-litre syringe at low, medium and high flow rates. The Innocor 
gas analyser had recently been serviced, including a gas calibration. 
All tests were performed on the same day (December 17, 2011), 
and the air temperature and relative humidity inside the phantom 
lung were measured on three occasions during the testing period 
to confirm that BTPS conditions in the lung compartment were 
maintained. This was performed using measuring probes that were 
inserted through a small hole in the lung phantom lid. The hole 
was then sealed prior to testing.
 Testing was performed at FRC values between 500 and 4,000 ml, 
at 500-ml intervals, in order to simulate lung volumes of young chil-
dren through to large adults. VT was set to approximately one third 
of FRC. The respiratory rate was set at between 12 and 24 breaths/min; 
larger respiratory rates were used with smaller lung volumes in order 
to accurately simulate the physiology of young children. At FRC val-
ues of 500, 1,000, 2,000, 3,000 and 4,000 ml, experiments were per-
formed at three different respiratory rates in order to assess if accu-
racy was affected by changes in this parameter. Each of the 20 exper-
iments was performed in triplicate, making a total of 60 washout runs.
 The testing procedure consisted of the following steps.
 (i) The water level, IPAP and EPAP settings were adjusted to 
achieve the required FRC and VT within the phantom lung. This 
was facilitated by a measuring scale affixed to the inside of the lung 
model, which was utilised to measure the water level at its highest 
and lowest points during the respiratory cycle. The respiratory rate 
was set using the ventilator controls.
 (ii) An air mixture containing 0.2% SF 6 was passively insuf-
flated into the lung phantom via an open-circuit bypass flow sys-
tem, and expiratory SF 6 concentration was monitored online using 
the Innocor gas analyser. The flow rate of SF 6 through the open 
circuit was increased sufficiently to allow complete wash-in of SF 6 .
 (iii) Once complete equilibration (wash-in) had occurred, 
meaning that the inspired and expired SF 6 concentrations were 
equal, the bypass flow system was removed so that the phantom 
lung inspired from ambient air. Expiratory SF 6 concentration con-
tinued to be monitored during the wash-out phase, and the exper-
iment was terminated once the expired SF 6 concentration fell below 
0.005% (1/40th of the initial value) for three consecutive breaths.
 Subjects 
 Ten healthy subjects with no history of respiratory disease and 
14 patients with a clinical diagnosis of asthma were recruited. Sub-
jects were aged over 18 years, and were never-smokers or ex-smok-
ers with  ≤ 10 pack years of smoking history. The study protocol was 
approved by the National Research Ethics Committee, East Mid-
lands Leicester (approval No. 08/H0406/189), and all subjects gave 
their written informed consent.
48.0 cm
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 Fig. 2. Schematic diagram of the lung model showing the dimensions of the outer ( a ) and inner ( b ) tanks. 
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 In vivo Testing Procedure 
 MBW was performed in triplicate at a single visit between the 
dates of June 15, 2010, and March 2, 2011, using the method ini-
tially described by Horsley et al.  [2] . Participants wore a nose clip 
and breathed an air mixture containing 0.2% SF 6 , via an open-
circuit bypass flow system connected to an Innocor gas analyser, 
until the concentration in their exhaled breath reached a steady 
state. For in vivo tests a Douglas bag, fitted with a two-way valve, 
was utilised as a reservoir for SF 6 . Participants were encouraged to 
maintain a steady respiratory rate of approximately 12 breaths/
min, and a constant VT volume of 1 litre  [5] , using a real-time vi-
sual display of inspired volume as a guide. Participants were then 
switched to breathing room air during an expiration and asked to 
continue breathing at the same respiratory rate and VT. The end-
tidal concentration of SF 6 in exhaled breath (C et ) was recorded 
during this washout phase until it reached 1/40th of the original 
concentration (0.005%).
 Data and Statistical Analysis 
 The washout data were transferred to a laptop computer, where 
they were processed and analysed using custom software written 
with TestPoint (Measurement Computing Corp., Norton, Mass., 
USA). This included a calculation of the flow-gas delay time, which 
was used to synchronise the flow and SF 6 concentration signals. 
We calculated the flow-gas delay time using the method based 
upon re-inspiration of SF 6 from the post-capillary dead space, as 
described in recent guidelines  [1] . Specifically, the time point at 
which the post-capillary dead space had been inspired was aligned 
with the time point at which the inspired SF 6 concentration fell to 
50% of its initial value. FRC was calculated by dividing the total 
volume of SF 6 expired by the difference between the SF 6 concentra-
tions at the beginning and end of the washout period  [3] . The total 
volume of expired SF 6 was calculated by integrating flow and SF 6 
concentration over the course of each expiration, and subtracting 
the re-inspired SF 6 volume, which was in turn calculated by inte-
grating flow and SF 6 concentration over the course of each inspira-
tion. LCI was defined as the cumulative expired volume at the 
point at which C et fell to 1/40th of its initial value, divided by the 
FRC  [6] .
 Statistical analyses were performed using Prism version 6 
(GraphPad, San Diego, Calif., USA). Results from the in vitro lung 
model were displayed as a Bland-Altman plot  [7] of FRC measured 
using MBW (FRC mbw ) against FRC calculated using the measuring 
scale affixed to the lung model (FRC calc ). The percentage difference 
between FRC mbw and FRC calc was also compared between washout 
tests with low, intermediate and high respiratory rates, using one-
way analysis of variance. The mean coefficient of variation (CoV) 
of triplicate values was compared across the three sets of measure-
ments (lung model, healthy subjects and patients with asthma) us-
ing one-way analysis of variance with Bonferroni correction for 
multiple comparisons.
 Results 
 The Innocor system measured FRC with high precision. 
 Table  1 lists the 60 in vitro experiments that were per-
formed, with the values of FRC calc and FRC mbw given in 
each case.  Figure 3 shows Bland-Altman plots  [7] of  FRC mbw 
against FRC calc , with the absolute and percentage differ-
ence between FRC mbw and FRC calc plotted on the y-axis. 
The mean absolute bias of FRC mbw with respect to FRC calc 
was 12.6 ml, and the 95% limits of agreement were –68.6 
and 93.7 ml. The mean percentage bias of FRC mbw with re-
spect to FRC calc was –0.4%, and the 95% limits of agree-
ment were –4.6 and 3.9%. There was a significant positive 
correlation between the mean of FRC mbw and FRC calc and 
the percentage difference between these values (Pearson 
correlation coefficient = 0.82, p < 0.0001). The equation of 
the regression line was y = 0.001462x – 3.653. The regres-
sion line crossed the x-axis at a lung volume of 2,499 ml, 
which was therefore the point of zero bias. The mean bias 
at a lung volume of 500 ml was –3.9% and at a lung volume 
of 4,000 ml was 1.9%. The respiratory rate did not have an 
independent effect on the bias. The mean bias of FRC mbw 
with respect to FRC calc in washout runs with low, interme-
diate and high respiratory rates was –0.3, –0.9 and –0.3%, 
respectively, with no statistically significant difference be-
tween the sets of washout experiments.  Figure 4 shows the 
error in LCI, defined as the absolute difference between the 
measured and the calculated LCI, against FRC calc . LCI was 
measured accurately at lung volumes at or above 1,500 ml, 
with an error of less than 0.4 units in each case. However, 
Table 1.  List of experiments performed with results
Experimental conditions  FRCmbw results, ml
VT, ml respiratory
rate, min–1
FRCcalc, ml Test 1 Test 2 Test 3
224 16 477 460 467 462
205 20 496 465 474 475
187 24 496 478 486 473
243 16 944 902 917 922
261 24 1,019 1,006 995 1,009
336 20 1,093 1,077 1,097 1,077
448 16 1,467 1,449 1,464 1,476
523 12 1,971 1,925 1,997 2,001
504 16 1,971 1,936 1,981 1,960
467 20 2,008 2,020 2,016 2,038
541 12 2,550 2,512 2,551 2,543
1,027 12 2,587 2,558 2,606 2,610
990 20 2,998 3,039 3,020 3,015
1,046 16 2,998 3,056 3,008 2,998
485 12 3,035 3,045 3,097 3,108
1,008 12 3,072 3,068 3,084 3,096
448 12 3,577 3,599 3,631 3,595
1,008 12 3,950 4,100 3,985 4,072
971 16 3,987 3,990 4,046 4,091
952 20 4,006 4,047 4,135 4,050
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at lung volumes of 500 or 1,000 ml, LCI was in some cases 
overestimated by up to 1.1 units.
 The healthy participants comprised 4 women and 6 
men with a mean age of 46.4 years (SD 19.4), while the 
patients with asthma comprised 7 women and 7 men with 
a mean age of 59.0 years (11.9). The mean FRC mbw was 
2,796 ml (896) in healthy controls and 2,555 ml (794) in 
patients with asthma. The mean LCI was 7.07 (1.07) in 
healthy controls and 8.12 (1.46) in patients with asthma.
 The mean CoV of triplicate FRC mbw measurements 
was 1.0% (range 0.4–2.2) in vitro, 4.0% (1.9–5.3) in healthy 
controls and 2.9% (0.4–5.4) in patients with asthma. These 
values were significantly different across the three sets of 
measurements (p < 0.0001). In particular, the mean CoV 
was significantly lower in vitro than in both healthy (p < 
0.0001) and asthma (p < 0.001) groups, but did not differ 
significantly between the healthy and asthma groups. The 
difference in mean CoV between in vitro and healthy 
group measurements was 3.0% (95% confidence interval 
of difference: 2.5–3.5%), while the difference in mean CoV 
between in vitro and asthma group measurements was 
1.9% (95% confidence interval of difference: 1.0–2.7%). 
The in vitro CoV of FRC mbw was not significantly related 
to the respiratory rate. The mean CoV was 1.1% (0.5–2.2) 
with a respiratory rate of 12 breaths/min, 1.0% (0.8–1.3) 
with a respiratory rate of 16 breaths/min, and 0.9% (0.4–
1.4) with a respiratory rate of 20 or 24 breaths/min (no 
significant difference between groups of tests). The mean 
CoV of triplicate LCI measurements was 1.2% (0.0–4.0) in 
vitro, 4.6% (0.4–12.1) in healthy controls, and 3.3% (0.3–
7.0) in patients with asthma.
 Discussion 
 In this study, we utilised a one-compartment acrylic 
glass lung model under BTPS conditions to validate a 
practical and portable MBW system that uses an Inno-
cor photoacoustic gas analyser, with SF 6 as the inert 
tracer gas. Of note, this open-circuit system is distinct 
from the closed-circuit setup that was found to have 
poor intra-subject variability and patient acceptability 
by Pittman et al.  [8] . We found good agreement between 
FRC measured using Innocor (FRC mbw ) and FRC calcu-
lated from the known dimensions of the lung model 
(FRC calc ), with a mean bias of FRC mbw with respect to 
FRC calc of –0.4%, and 95% limits of agreement of –4.6 
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and 3.9%, comfortably below the recommended maxi-
mum error of 5%  [1] . An identical lung model has been 
previously used to validate a commercially available 
open-circuit nitrogen MBW system (Exhalyzer D TM , 
Eco Medics AG, Duernten Switzerland)  [4] . These au-
thors found that for lung volumes above 500 ml, there 
was a mean bias of 0.4%, with 95% limits of agreement 
of –4.0 and 4.7%, respectively. We therefore conclude 
that the accuracy of FRC measurements using Innocor 
and Exhalyzer D is similar within the FRC range of 
500–4,000 ml. We found that the mean coefficient of 
variation of triplicate FRC measurements was 1.0% in 
vitro and 4.0% in vivo, suggesting that the majority of 
between-measurement variability in vivo was caused by 
biological rather than technical factors. Singer et al.  [4] 
obtained similar values using the Exhalyzer D system, 
namely 1.4 and 4.5%, respectively, suggesting that the 
two systems perform approximately equally with re-
spect to within-visit repeatability.
 The Innocor-based system appeared to slightly un-
derestimate FRC when lung volumes were small and 
overestimate it when volumes were large. We speculated 
that this may have been due to cyclical heating and 
cooling of the pneumotachometer during the respira-
tory cycle, resulting in non-linearity of flow measure-
ment. On closer examination of our data, we ascer-
tained that the source of this FRC-dependent bias was 
the correction for re-inspired SF 6 , which appeared to 
overcompensate at low lung volumes, resulting in arti-
ficially low FRC values. In particular, inspiratory flows 
were overestimated at low lung volumes, particularly 
below an FRC of 1,500 ml, resulting in an overestima-
tion of re-inspired SF 6 volume. Of note, this FRC-de-
pendent bias was not seen with the Exhalyzer D  [4] , 
which utilises an ultrasonic flowmeter. However, the er-
ror in FRC measurements with Exhalyzer D increased 
with increasing respiratory rate  [4] , an effect that we did 
not observe with the Innocor-based system. We further 
examined the accuracy of LCI measurements per-
formed using Innocor at different lung volumes and 
found that at lung volumes of 1,500 ml or above, there 
was good agreement between measured and calculated 
LCI, whereas at lung volumes below 1,500 ml, LCI was 
often overestimated by up to 1.1 units. This suggests 
that at lung volumes corresponding to older children or 
adults, the small bias observed in FRC does not signifi-
cantly affect LCI measurements.
 The open-circuit Innocor-based system described in 
this manuscript is practical and convenient, and could 
potentially be utilised in clinical practice and multicentre 
trials in both older children and adults. However, our in 
vitro results at low lung volumes suggest that the system 
would require further modification before it could be 
used reliably in young children and infants. Such modifi-
cation would be likely to include the replacement of the 
pneumotachometer with a smaller model that has a lower 
flow range. Moreover, Innocor employs side-stream sam-
pling of gas at a flow rate of 120 ml/min  [1] , which may 
have a significant influence at low VTs. Furthermore, the 
response time of the photoacoustic analyser is relatively 
slow (154 ms)  [1] , which may be particularly relevant at 
fast respiratory rates, as seen in young children. These lat-
ter two issues would require further technical develop-
ment by the manufacturers of Innocor. There are a num-
ber of additional improvements that could be made rela-
tively easily to further increase the general applicability of 
this technology to the performance of MBW. Foremost 
among these is that data analysis is currently performed 
off-line, which is relatively time consuming. It would, 
however, be straightforward to incorporate FRC and LCI 
calculations into the on-board Innocor software in the 
future. Ideally, this on-board software would also include 
a user-friendly patient interface to allow VT to be target-
ed by the patient to a set value. Our current system re-
quires the patient to target their VT using a numerical 
display on a separate laptop computer. A further limita-
tion of the current Innocor setup is the requirement of 
SF 6 , which is restricted in some countries as it acts as a 
greenhouse gas.
 In conclusion, the open-circuit MBW system utilis-
ing SF 6 as the inert tracer gas and an Innocor photo-
acoustic gas analyser is both accurate and repeatable in 
adults, and is comparable in these respects to the Exh-
alyzer D MBW system. These results provide increased 
confidence in previous and future research studies con-
ducted using the Innocor-based system, and suggest its 
potential to develop into a commercially available MBW 
platform. Further modifications to the system would 
be required to facilitate its use in young children and 
infants.
 Acknowledgements 
 The research leading to these results has received funding from 
the European Union Seventh Framework Programme FP7/2007–
2013 under grant agreement No. 270194, as part of the Airway 
Disease Predicting Outcomes through Patient Specific Computa-
tional Modelling (AirPROM) project (www.airprom.eu). Florian 
Singer was supported by the European Respiratory Society, STRTF 
fellowship No. 81-2011. 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.2
06
.7
5 
- 1
/2
9/
20
15
 4
:4
4:
43
 P
M
 Gonem/Singer/Corkill/Singapuri/
Siddiqui/Gustafsson 
 Respiration 2014;87:462–468 
DOI: 10.1159/000357786
468
 References 
 1 Robinson P, Latzin P, Verbanck S, Hall GL, 
Horsley A, Gappa M, Thamrin C, Arets HG, 
Aurora P, Fuchs S, King GG, Lum S, Macleod 
K, Paiva M, Pillow J, Ranganathan S, Ratjen F, 
Singer F, Sonnappa S, Stocks J, Subbarao P, 
Thompson B, Gustafsson PM: Consensus 
statement for inert gas washout measurement 
using multiple and single breath tests. Eur 
Respir J 2013; 41: 507–522. 
 2 Horsley AR, Gustafsson PM, Macleod KA, 
Saunders C, Greening AP, Porteous DJ, Da-
vies JC, Cunningham S, Alton EW, Innes JA: 
Lung clearance index is a sensitive, repeatable 
and practical measure of airways disease in 
adults with cystic fibrosis. Thorax 2008; 63: 
 135–140. 
 3 Darling RC, Cournand A, Richards DW: 
Studies on the intrapulmonary mixture of 
gases. III. An open circuit method for measur-
ing residual air. J Clin Invest 1940; 19: 609–
618. 
 4 Singer F, Houltz B, Latzin P, Robinson P, Gus-
tafsson P: A realistic validation study of a new 
nitrogen multiple-breath washout system. 
PLoS One 2012; 7:e36083. 
 5 Verbanck S, Schuermans D, van Muylem A, 
Noppen M, Paiva M, Vincken W: Ventilation 
distribution during histamine provocation. J 
Appl Physiol 1997; 83: 1907–1916. 
 6 Bouhuys A, Lichtneckert S, Lundgren C, Lun-
din G: Voluntary changes in breathing pat-
tern and N2 clearance from lungs. J Appl 
Physiol 1961; 16: 1039–1042. 
 7 Bland JM, Altman DG: Statistical methods for 
assessing agreement between two methods 
of clinical measurement. Lancet 1986; 1: 307–
310. 
 8 Pittman JE, Johnson RC, Jones PW, Davis SD: 
Variability of a closed, rebreathing setup for 
multiple breath wash-out testing in children. 
Pediatr Pulmonol 2012; 47: 1242–1250. 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.2
06
.7
5 
- 1
/2
9/
20
15
 4
:4
4:
43
 P
M
